Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:DGNOFOTCMKTS:FRXIFOTCMKTS:LNGLYOTCMKTS:NICXF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDGNOFDIAGNOS$0.14-1.1%$0.16$0.13▼$0.31$14.41M0.2536,770 shs185,357 shsFRXIFFRX Innovations$0.04$0.04$0.02▼$0.24$4.93M1.42N/AN/ALNGLYLiquefied Natural Gas$0.09-10.0%$0.09$0.03▼$0.45$12.98M0.3648,717 shs26,000 shsNICXFNicox$0.25$0.25$0.25▼$0.28$17.23M0.29N/AN/A13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDGNOFDIAGNOS-1.06%-5.41%-15.20%-29.65%-35.25%FRXIFFRX Innovations0.00%0.00%0.00%0.00%0.00%LNGLYLiquefied Natural Gas0.00%0.00%0.00%0.00%0.00%NICXFNicox0.00%0.00%0.00%0.00%-43.18%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDGNOFDIAGNOSN/AN/AN/AN/AN/AN/AN/AN/AFRXIFFRX InnovationsN/AN/AN/AN/AN/AN/AN/AN/ALNGLYLiquefied Natural GasN/AN/AN/AN/AN/AN/AN/AN/ANICXFNicoxN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDGNOFDIAGNOS 0.00N/AN/AN/AFRXIFFRX Innovations 0.00N/AN/AN/ALNGLYLiquefied Natural Gas 0.00N/AN/AN/ANICXFNicox 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDGNOFDIAGNOS$80K178.26N/AN/AN/A∞FRXIFFRX Innovations$3.11M1.58N/AN/A$0.01 per share4.16LNGLYLiquefied Natural GasN/AN/AN/AN/AN/AN/ANICXFNicox$5.52M3.12N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDGNOFDIAGNOS-$3.08M-$0.04N/A∞N/A-4,039.47%N/A-157.63%7/16/2025 (Estimated)FRXIFFRX Innovations-$8.51M-$0.09N/A∞N/AN/AN/A-8.79%N/ALNGLYLiquefied Natural GasN/AN/A0.00∞N/AN/AN/AN/AN/ANICXFNicox-$29.25MN/A0.00∞N/AN/AN/AN/A7/16/2025 (Estimated)Latest FRXIF, DGNOF, NICXF, and LNGLY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/28/2025Q4 2025DGNOFDIAGNOS-$0.0070-$0.01-$0.0031-$0.01$0.09 million$0.01 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDGNOFDIAGNOSN/AN/AN/AN/AN/AFRXIFFRX InnovationsN/AN/AN/AN/AN/ALNGLYLiquefied Natural GasN/AN/AN/AN/AN/ANICXFNicoxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDGNOFDIAGNOS1.231.111.11FRXIFFRX InnovationsN/A0.900.90LNGLYLiquefied Natural GasN/AN/AN/ANICXFNicoxN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDGNOFDIAGNOSN/AFRXIFFRX InnovationsN/ALNGLYLiquefied Natural GasN/ANICXFNicoxN/AInsider OwnershipCompanyInsider OwnershipDGNOFDIAGNOSN/AFRXIFFRX InnovationsN/ALNGLYLiquefied Natural GasN/ANICXFNicoxN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDGNOFDIAGNOSN/A101.86 millionN/ANot OptionableFRXIFFRX Innovations21118.46 millionN/ANot OptionableLNGLYLiquefied Natural GasN/A144.17 millionN/ANot OptionableNICXFNicox2868.92 millionN/ANot OptionableFRXIF, DGNOF, NICXF, and LNGLY HeadlinesRecent News About These CompaniesNicox: Notice of the Ordinary and Extraordinary Shareholders’ Meeting on June 27, 2025 and appointment of an ad hoc representativeJune 6, 2025 | santelog.comSNICOX SA: Nicox Announces up to €3 million in Milestone Payments from Kowa in 2025 as NCX 470 Prepares to Enter Phase 3 Clinical Trials in JapanMay 27, 2025 | finanznachrichten.deNicox Announces up to €3 million in Milestone Payments from Kowa in 2025 as NCX 470 Prepares to Enter Phase 3 Clinical Trials in JapanMay 27, 2025 | finance.yahoo.comNicox releases results from Whistler phase 3b trial in IOP lowering eye dropsMay 15, 2025 | ophthalmologytimes.comONicox Announces Results of the Exploratory Whistler Phase 3b Glaucoma TrialMay 14, 2025 | finance.yahoo.comNicOx S.A.May 10, 2025 | barrons.comNicox Provides Full Year 2024 Financial ResultsApril 30, 2025 | finance.yahoo.comNicox announces last patient completed final visit in Whistler Phase 3b clinical trialMarch 24, 2025 | ophthalmologytimes.comONICOX SA: Nicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma TrialMarch 19, 2025 | finanznachrichten.deNicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma TrialMarch 19, 2025 | markets.businessinsider.comNicox presents new analysis from the NCX 470 Mont Blanc trialMarch 7, 2025 | thepharmaletter.comTNICOX SA: Nicox Extends Cash Runway into Q4 2025March 6, 2025 | finanznachrichten.deNicox Presents New Analysis from the NCX 470 Mont Blanc Trial and Provides Development UpdateMarch 3, 2025 | markets.businessinsider.comNicox Announces Scientific Presentation and Conference Attendance in H1 2025January 29, 2025 | markets.businessinsider.comNiconico's Mature Illustration Service Niconico Shunga to End ServiceJanuary 18, 2025 | animenewsnetwork.comANiconico Shunga Latest Japanese Retailer to Shutter Because of “Current Social Environment”January 18, 2025 | otakuusamagazine.comOJapanese publisher Kadokawa paid $3 million to Russia-linked hacker group after cyberattackDecember 12, 2024 | msn.comSquare Enix Lays Out Streaming Rules for Dragon Quest 3 RemakeNovember 9, 2024 | gamerant.comGBeijing says it has consistent US policy, as Asian nations react to Trump’s winNovember 7, 2024 | straitstimes.comSRe:Zero Season 3 Episode 6 Release Date, Where To Stream, Expected Plot And MoreNovember 6, 2024 | msn.comMedia Sentiment Over TimeFRXIF, DGNOF, NICXF, and LNGLY Company DescriptionsDIAGNOS OTCMKTS:DGNOF$0.14 0.00 (-1.06%) As of 06/26/2025 03:21 PM EasternDIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.FRX Innovations OTCMKTS:FRXIF$0.04 0.00 (0.00%) As of 06/20/2025FRX Innovations Inc. manufactures and sells flame-retardant polyphosphate polymers in Asia, Europe, and internationally. The company's products including homopolymers used in carpets, textiles, connectors, wires and cables, transparent sheet products, and transparent blown films; Co-polymers used in housings, sheets, fibers, and lightings; and reactive oligomers used in decorative laminates, wall panels, copper clad laminates for printed circuit boards, and protective sheets and coatings. It serves building and construction, fiber, textiles, electrical, electronics, and transportation sectors. The company was formerly known as FRX Polymers Inc. and changed its name to FRX Innovations Inc. in May 2022. FRX Innovations Inc. is based in Vancouver, Canada.Liquefied Natural Gas OTCMKTS:LNGLY$0.09 -0.01 (-10.00%) As of 07/2/2021Liquefied Natural Gas Limited, together with its subsidiaries, engages in the identification and progression of liquefied natural gas (LNG) development projects to facilitate the production and sale of LNG. It operates through LNG Infrastructure, and Technology and Licensing segments. The company's projects include the Magnolia LNG project located in Lake Charles, Louisiana, the United States; and the Bear Head LNG project situated in Point Tupper, Richmond County, Nova Scotia, Canada. It also designs, develops, owns, and patents OSMR LNG liquefaction process. The company is headquartered in Houston, Texas.Nicox OTCMKTS:NICXF$0.25 0.00 (0.00%) As of 06/25/2025Nicox S.A. operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial. The company is also developing NCX 4251, a novel patented ophthalmic suspension of fluticasone propionate nanocrystals that is in Phase 2b clinical trial for the treatment of dry eye disease; and NCX 1728, an NO-donating Phosphodiesterase-5 inhibitor, which is in preclinical evaluation. It offers VYZULTA, a latanoprostene bunod ophthalmic solution to treat patients with open-angle glaucoma or ocular hypertension; and ZERVIATE, a cetirizine ophthalmic solution for the treatment of ocular itching associated with allergic conjunctivitis. The company was incorporated in 1996 and is headquartered in Valbonne, France. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Super Micro’s Bold $2B Bond Plan Signals 35% Premium Upside Is IBM’s AI Transformation Powering a Sustained Rally? Analysts Supercharge AMD Stock Ahead of Q2 AI Catalyst Amazon: Why Some Are Growing Bearish, and Why They’re Wrong ASML Keeps Buying Back Its Own Stock—Chasing Discount and Upside Astera Labs: AI Infrastructure Play With Significant Growth Ahead Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
